Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study.
Diana-Leh-Ching NgNatasya Marliana Bt Abdul MalikChee-Shee ChaiGreta-Miranda-Kim-Choo GohSeng-Beng TanPing-Chong BeeGin-Gin GanAsri B SaidPublished in: Health and quality of life outcomes (2020)
Majority of the patients on long-term warfarin for NVAF in the current study have poor TTR. Their HRQoL and treatment satisfaction are independent of their TTR. Achieving a good TTR do not compromise the HRQoL and treatment satisfaction. Therefore, appropriate measures should be taken to optimise INR control, failing which direct oral anticoagulant therapy should be considered.
Keyphrases
- atrial fibrillation
- end stage renal disease
- newly diagnosed
- ejection fraction
- venous thromboembolism
- prognostic factors
- heart failure
- direct oral anticoagulants
- coronary artery disease
- left atrial
- left atrial appendage
- stem cells
- percutaneous coronary intervention
- aortic valve
- left ventricular
- cell therapy
- patient reported